Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug
Glenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated RRMM patients. The tri-specific antibody showed high response rates and a favorable safety profile in early trials. Complete results will be presented at (...)
Site référencé: The Economic Times
The Economic Times
Rupee hits a 6-month high at 83.78/$, erases 2025 losses
3/05/2025
JSW Steel-Bhushan Power fallout : In the absence of legal certainty, foreign investors may shun stressed assets
3/05/2025
Door knocks and DNA tests : How Trump administration plans to keep tabs on 450,000 migrant kids
2/05/2025
Drones bomb aid ship bound for Gaza ; NGO blames Israel
2/05/2025
$163-billion US budget cut plan : Education, housing to be hit
2/05/2025
China mulls opening communication lines with US on trade
2/05/2025
